Cargando…
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients
BACKGROUND: To develop a sensitive risk score predicting the risk of mortality in patients with coronavirus disease 2019 (COVID-19) using complete blood count (CBC). METHODS: We performed a retrospective cohort study from a total of 13,138 inpatients with COVID-19 in Hubei, China, and Milan, Italy....
Autores principales: | Liu, Hui, Chen, Jing, Yang, Qin, Lei, Fang, Zhang, Changjiang, Qin, Juan-Juan, Chen, Ze, Zhu, Lihua, Song, Xiaohui, Bai, Liangjie, Huang, Xuewei, Liu, Weifang, Zhou, Feng, Chen, Ming-Ming, Zhao, Yan-Ci, Zhang, Xiao-Jing, She, Zhi-Gang, Xu, Qingbo, Ma, Xinliang, Zhang, Peng, Ji, Yan-Xiao, Zhang, Xin, Yang, Juan, Xie, Jing, Ye, Ping, Azzolini, Elena, Aghemo, Alessio, Ciccarelli, Michele, Condorelli, Gianluigi, Stefanini, Giulio G., Xia, Jiahong, Zhang, Bing-Hong, Yuan, Yufeng, Wei, Xiang, Wang, Yibin, Cai, Jingjing, Li, Hongliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831644/ https://www.ncbi.nlm.nih.gov/pubmed/33521746 http://dx.doi.org/10.1016/j.medj.2020.12.013 |
Ejemplares similares
-
Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
por: Cheng, Xu, et al.
Publicado: (2020) -
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19
por: Zhang, Xiao-Jing, et al.
Publicado: (2020) -
Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
por: Lei, Fang, et al.
Publicado: (2023) -
The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19
por: Cai, Jingjing, et al.
Publicado: (2021) -
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19
por: Zhang, Peng, et al.
Publicado: (2020)